Skip to main content

Arterial Disease of Legs

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Concept Medical
Concept MedicalFL - Tampa
1 program
MagicTouch PTA Sirolimus drug coated balloonN/A1 trial
Active Trials
NCT06182397Recruiting368Est. Feb 2031

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
2031
Concept MedicalMagicTouch PTA Sirolimus drug coated balloon

Clinical Trials (1)

Total enrollment: 368 patients across 1 trials

NCT06182397Concept MedicalMagicTouch PTA Sirolimus drug coated balloon

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

Start: Jan 2025Est. completion: Feb 2031368 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 368 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.